Mb, Levis & Associates, LLC Immunome Inc. Transaction History
Mb, Levis & Associates, LLC
- $215 Billion
- Q1 2025
A detailed history of Mb, Levis & Associates, LLC transactions in Immunome Inc. stock. As of the latest transaction made, Mb, Levis & Associates, LLC holds 2,373 shares of IMNM stock, worth $21,048. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,373
Previous 2,373
-0.0%
Holding current value
$21,048
Previous $25.2 Million
36.63%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding IMNM
# of Institutions
131Shares Held
45.9MCall Options Held
38.7KPut Options Held
2.05M-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.5MShares$48.8 Million0.04% of portfolio
-
Redmile Group, LLC San Francisco, CA4.83MShares$42.8 Million3.87% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.88MShares$34.4 Million1.86% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$33.3 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X03.46MShares$30.7 Million0.02% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $108M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...